These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 9200472

  • 21. Transplantability and sensitivity to natural killer cells of aclarubicin-resistant murine lymphoma.
    Sugimoto Y, Hirakawa Y, Tanaka N, Tahara M, Sato I, Nishimura T, Suzuki H, Tanaka N.
    Cancer Res; 1986 Nov; 46(11):5646-8. PubMed ID: 3463416
    [Abstract] [Full Text] [Related]

  • 22. Characterization of tumor progression from threshold tumor inocula: evidence for natural resistance.
    Brown GW, Chow DA.
    Int J Cancer; 1985 Mar 15; 35(3):385-93. PubMed ID: 3972473
    [Abstract] [Full Text] [Related]

  • 23. Variant generation and selection: an in vitro model of tumor progression.
    Chow DA.
    Int J Cancer; 1984 Apr 15; 33(4):541-5. PubMed ID: 6706435
    [Abstract] [Full Text] [Related]

  • 24. Altered CD45 isoform expression affects lymphocyte function in CD45 Tg mice.
    Tchilian EZ, Dawes R, Hyland L, Montoya M, Le Bon A, Borrow P, Hou S, Tough D, Beverley PC.
    Int Immunol; 2004 Sep 15; 16(9):1323-32. PubMed ID: 15302847
    [Abstract] [Full Text] [Related]

  • 25. Epitope-specific antibody response to HT-1080 fibrosarcoma cells by mimotope immunization.
    Popkov M, Sidrac-Ghali S, Alakhov V, Mandeville R.
    Clin Cancer Res; 2000 Sep 15; 6(9):3629-35. PubMed ID: 10999755
    [Abstract] [Full Text] [Related]

  • 26. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI, Taraban VY, Seledtsova GV, Samarin DM, Avdeev IV, Senyukov VV, Kozlov VA.
    Cell Immunol; 1997 Nov 25; 182(1):12-9. PubMed ID: 9427805
    [Abstract] [Full Text] [Related]

  • 27. Phenotypic shifts in the L5178Y lymphoma population during progression of the tumor-dormant state in DBA/2 mice.
    Trainer DL, Wheelock EF.
    Cancer Res; 1984 Mar 25; 44(3):1063-71. PubMed ID: 6607108
    [Abstract] [Full Text] [Related]

  • 28. Characterization of L5178Y cell phenotypes isolated during progression of the tumor-dormant state in DBA2 mice.
    Trainer DL, Wheelock EF.
    Cancer Res; 1984 Jul 25; 44(7):2897-906. PubMed ID: 6609767
    [Abstract] [Full Text] [Related]

  • 29. Microscopic intratumoral dosimetry of radiolabeled antibodies is a critical determinant of successful radioimmunotherapy in B-cell lymphoma.
    Du Y, Honeychurch J, Glennie M, Johnson P, Illidge T.
    Cancer Res; 2007 Feb 01; 67(3):1335-43. PubMed ID: 17283171
    [Abstract] [Full Text] [Related]

  • 30. 4-1BB promotes long-term survival in skin allografts treated with anti-CD45RB and anti-CD40L monoclonal antibodies.
    Lee J, Lee EN, Kim EY, Lee HJ, Park HJ, Sun CL, Lee SK, Joh JW, Lee KW, Kwon GY, Kim SJ.
    Transplant Proc; 2005 Feb 01; 37(1):123-5. PubMed ID: 15808569
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Tumor progression in vitro: tumor-promoter-induced reversible decrease in natural immune susceptibility.
    Sandstrom PA, Chow DA.
    Carcinogenesis; 1988 Nov 01; 9(11):1967-73. PubMed ID: 3180334
    [Abstract] [Full Text] [Related]

  • 34. Radioimmunotherapy of CD22-expressing Daudi tumors in nude mice with a 90Y-labeled anti-CD22 monoclonal antibody.
    Vallera DA, Brechbiel MW, Burns LJ, Panoskaltsis-Mortari A, Dusenbery KE, Clohisy DR, Vitetta ES.
    Clin Cancer Res; 2005 Nov 01; 11(21):7920-8. PubMed ID: 16278417
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Synergistic tolerance induced by LF15-0195 and anti-CD45RB monoclonal antibody through suppressive dendritic cells.
    Min WP, Zhou D, Ichim TE, Xia X, Zhang X, Yang J, Huang X, Garcia B, Dutartre P, Jevnikar AM, Strejan GH, Zhong R.
    Transplantation; 2003 Apr 27; 75(8):1160-5. PubMed ID: 12717196
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.